These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10726603)

  • 1. Trail making test in chronic toxic encephalopathy: performance and discriminative potential.
    Nilson L; Barregård L; Bäckman L
    Clin Neuropsychol; 1999 Aug; 13(3):314-27. PubMed ID: 10726603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing mental flexibility: neuroanatomical and neuropsychological correlates of the Trail Making Test in elderly people.
    Oosterman JM; Vogels RL; van Harten B; Gouw AA; Poggesi A; Scheltens P; Kessels RP; Scherder EJ
    Clin Neuropsychol; 2010 Feb; 24(2):203-19. PubMed ID: 20162494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuropsychological diagnosis of chronic solvent induced encephalopathy (CSE)--a reanalysis of neuropsychological test results in a group of CSE patients diagnosed 20 years ago, based on comparisons with matched controls.
    Bast-Pettersen R
    Neurotoxicology; 2009 Nov; 30(6):1195-201. PubMed ID: 19422849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suboptimal performance on neuropsychological tests in patients with suspected chronic toxic encephalopathy.
    van Hout MS; Schmand B; Wekking EM; Hageman G; Deelman BG
    Neurotoxicology; 2003 Aug; 24(4-5):547-51. PubMed ID: 12900068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the diagnostic value of the trail making test for suboptimal effort in acquired brain injury rehabilitation patients.
    Powell MR; Locke DE; Smigielski JS; McCrea M
    Clin Neuropsychol; 2011 Jan; 25(1):108-18. PubMed ID: 21113855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive correlates of the trail making test for older children in patients with traumatic brain injury.
    Thaler NS; Allen DN; Hart JS; Boucher JR; McMurray JC; Mayfield J
    Arch Clin Neuropsychol; 2012 Jun; 27(4):446-52. PubMed ID: 22512933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of occupational exposure to manganese dust and fume on neuropsychological functioning in Australian smelter workers.
    Summers MJ; Summers JJ; White TF; Hannan GJ
    J Clin Exp Neuropsychol; 2011 Jul; 33(6):692-703. PubMed ID: 21416424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trail Making Test in traumatic brain injury, schizophrenia, and normal ageing: sample comparisons and normative data.
    Periáñez JA; Ríos-Lago M; Rodríguez-Sánchez JM; Adrover-Roig D; Sánchez-Cubillo I; Crespo-Facorro B; Quemada JI; Barceló F
    Arch Clin Neuropsychol; 2007 May; 22(4):433-47. PubMed ID: 17336493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the capacity to drive in patients diagnosed of mild cognitive impairment and dementia].
    Badenes Guia D; Casas Hernanz L; Cejudo Bolivar JC; Aguilar Barberà M
    Neurologia; 2008 Nov; 23(9):575-82. PubMed ID: 18307055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Solvent-induced chronic encephalopathy; the 'solvent team' project].
    van der Hoek JA; Verberk MM; van der Laan G; Hageman G
    Ned Tijdschr Geneeskd; 2001 Feb; 145(6):256-60. PubMed ID: 11236371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trail making test, part B as a measure of executive control: validation using a set-switching paradigm.
    Arbuthnott K; Frank J
    J Clin Exp Neuropsychol; 2000 Aug; 22(4):518-28. PubMed ID: 10923061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of age and education on the Trail Making Test and determination of normative data for Japanese elderly people: the Tajiri Project.
    Hashimoto R; Meguro K; Lee E; Kasai M; Ishii H; Yamaguchi S
    Psychiatry Clin Neurosci; 2006 Aug; 60(4):422-8. PubMed ID: 16884442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive test performance and brain pathology.
    Serber SL; Kumar R; Woo MA; Macey PM; Fonarow GC; Harper RM
    Nurs Res; 2008; 57(2):75-83. PubMed ID: 18347478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of the Trail Making Test among patients suffering from depressive disorders and organic depressive disorders].
    Talarowska M; Krzysztof Z; Mossakowska-Wójcik J; Gałecki P
    Psychiatr Pol; 2012; 46(2):273-82. PubMed ID: 23214397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of attention measures in postconcussion syndrome.
    Cicerone KD; Azulay J
    Clin Neuropsychol; 2002 Aug; 16(3):280-9. PubMed ID: 12607141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executive function in sleep apnea: controlling for attentional capacity in assessing executive attention.
    Verstraeten E; Cluydts R; Pevernagie D; Hoffmann G
    Sleep; 2004 Jun; 27(4):685-93. PubMed ID: 15283003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of a computer-assisted neurobehavioral test battery in toxicant encephalopathy.
    Proctor SP; Letz R; White RF
    Neurotoxicology; 2000 Oct; 21(5):703-14. PubMed ID: 11130274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive function and risk of stroke in elderly men.
    Wiberg B; Lind L; Kilander L; Zethelius B; Sundelöf JE; Sundström J
    Neurology; 2010 Feb; 74(5):379-85. PubMed ID: 20124202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic solvent-induced encephalopathy: European consensus of neuropsychological characteristics, assessment, and guidelines for diagnostics.
    van Valen E; van Thriel C; Akila R; Nilson LN; Bast-Pettersen R; Sainio M; van Dijk F; van der Laan G; Verberk M; Wekking E
    Neurotoxicology; 2012 Aug; 33(4):710-26. PubMed ID: 22498091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contingent negative variation before and after hemodialysis among patients with end-stage renal disease.
    Bae JS; Park SS
    J Neurol Sci; 2008 Apr; 267(1-2):70-5. PubMed ID: 17950359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.